基本信息 产品详情 公司简介 推荐产品
网站主页 TWEAKR/TNFRSF12A, HUMAN, 重组蛋白 (HFC) TWEAKR/TNFRSF12A, Human, 重组蛋白 (hFc)
  • TWEAKR/TNFRSF12A, Human, 重组蛋白 (hFc)|TMPY-02757|TargetMol

TWEAKR/TNFRSF12A, Human, 重组蛋白 (hFc)|TMPY-02757|TargetMol

TWEAKR/TNFRSF12A Protein, Human, Recombinant (hFc)
22400 1mg 起订
上海 更新日期:2026-05-09

TargetMol 中国(陶术生物)

VIP1年
联系人:邵经理
电话:400-821-0310拨打
手机:15002144251 拨打
邮箱:xuexiang.shao@tsbiochem.com

产品详情:

中文名称:
TWEAKR/TNFRSF12A, Human, 重组蛋白 (hFc)
英文名称:
TWEAKR/TNFRSF12A Protein, Human, Recombinant (hFc)
品牌:
TargetMol
产地:
美国
保存条件:
Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6 months Shipping with blue ice/Shipping at ambient temperature.
产品类别:
抑制剂
货号:
TMPY-02757

Product Introduction

Bioactivity

名称TWEAKR/TNFRSF12A Protein, Human, Recombinant (hFc)
描述Fn14 (tumor necrosis factor receptor superfamily, member 12A), also known as TNFRSF12A, is the receptor for TNFSF12/TWEAK. Fn14 shares 82% amino acid identity with the mouse sequence. It contains a signal peptide, an extracellular domain, a membrane-anchoring domain, and a cytoplasmic domain. In response to FGF1, calf serum, or phorbol ester stimulation of human quiescent fibroblasts in vitro, the level of Fn14 is increased. A 1.2-kb FN14 transcript was expressed at high levels in heart, placenta, and kidney, at intermediate levels in lung, skeletal muscle, and pancreas, and at low levels in brain and liver. Also, elevated FN14 expression was found in human liver cancer cell lines and hepatocellular carcinoma specimens. Expression of mouse Fn14 was upregulated in hepatocellular carcinoma nodules that develop in 2 different transgenic mouse models of hepatocarcinogenesis. TNFRSF12A is the weak inducer of apoptosis in some cell types. It promotes angiogenesis and the proliferation of endothelial cells. TNFRSF12A may modulate cellular adhesion to matrix proteins.
存储条件Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6 months Shipping with blue ice/Shipping at ambient temperature.
关键字FN-14 | FN 14 | CD-266 | CD 266
br
TWEAKR|||tumor necrosis factor receptor superfamily member 12A|||FN14|||CD266|TargetMol

公司简介


成立日期 (14年)
注册资本 589.8595万人民币
员工人数 100-500人
年营业额 ¥ 1亿以上
经营模式 贸易,工厂,试剂,定制,服务
主营行业 天然产物,生物化工,化学试剂,生物技术服务

TWEAKR/TNFRSF12A, Human, 重组蛋白 (hFc)相关厂家报价

内容声明
拨打电话 立即询价